Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Debra Friedman

11 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    COGAALL08B1

    10/18/2010

    Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

    Health Services Research

    VICCREACH1447

    04/16/2014

    Retinoblastoma Survivor Study (RBSS)

    Other

    COGAPEC14B1

    01/20/2016

    The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

    Other

    COGALTE11C1

    08/21/2013

    ALTE11C1 - Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma

    Other

    COGALTE03N1

    04/20/2005

    Key Adverse Events after Childhood Cancer

    Prevention

    COGALTE1621

    10/03/2016

    Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Heart Failure (PREVENT-HF): A Phase 2b Randomized Placebo-Controlled (Carvedilol) Trial

    Treatment

    VICCPED1620

    12/08/2016

    A Phase I/II Study of Pembrolizumab (MK-3475) in Children with Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma

    Treatment

    COGAAML1531

    08/23/2016

    Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome

    Treatment

    COGAAML1331

    04/28/2016

    A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All-Trans Retinoic Acid

    Treatment

    COGAALL1331

    02/01/2016

    Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

    Treatment

    COGAHOD1331

    07/15/2015

    A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents


    Print this page for your doctor